Alligator Bioscience (Sweden) Today
| ATORX Stock | SEK 0.53 0.02 3.64% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Alligator Bioscience is selling for under 0.53 as of the 26th of November 2024; that is 3.64 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.51. Alligator Bioscience has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Alligator Bioscience AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Alligator Bioscience AB develops antibody-based pharmaceuticals for cancer treatment. Alligator Bioscience AB was founded in 2001 and is headquartered in Lund, Sweden. Alligator Bioscience operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 220.58 M outstanding shares. More on Alligator Bioscience AB
Moving against Alligator Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Alligator Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alligator Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alligator Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Vice President Discovery | Peter Ellmark |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Alligator Bioscience AB (ATORX) is traded on Stockholm Exchange in Sweden and employs 53 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 431.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alligator Bioscience's market, we take the total number of its shares issued and multiply it by Alligator Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alligator Bioscience operates under Biotechnology sector and is part of Health Care industry. The entity has 220.58 M outstanding shares.
Alligator Bioscience AB has accumulated about 278.15 M in cash with (127.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Alligator Bioscience Probability Of Bankruptcy
Ownership AllocationAlligator Bioscience holds a total of 220.58 Million outstanding shares. Alligator Bioscience AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alligator Ownership Details
Alligator Bioscience Risk Profiles
Although Alligator Bioscience's alpha and beta are two of the key measurements used to evaluate Alligator Bioscience's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.27 | |||
| Standard Deviation | 5.55 | |||
| Variance | 30.83 | |||
| Risk Adjusted Performance | (0.15) |
Alligator Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Alligator Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Alligator Bioscience Corporate Management
Elected by the shareholders, the Alligator Bioscience's board of directors comprises two types of representatives: Alligator Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alligator. The board's role is to monitor Alligator Bioscience's management team and ensure that shareholders' interests are well served. Alligator Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alligator Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sumeet MD | Chief Officer | Profile | |
| Malin Carlsson | Ex RD | Profile | |
| Marie Svensson | Chief Officer | Profile | |
| Julie Silber | Director Relations | Profile | |
| Sren Bregenholt | Chief Officer | Profile |
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.